MIRA PHARMACEUTICALS, INC.

MIRA · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.0B · 2 employees
87
SEC Filings
$0.954
Close 2026-06-23
2
Employees

Business Summary

PART I ITEM 1. Description of Business Overview MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA, the Company, we, us) is a clinical-stage pharmaceutical development company advancing a pipeline of novel oral therapeutics targeting neurologic, neuropsychiatric, metabolic, and addiction-related disorders. The Company holds exclusive rights in the United States, Canada, and Mexico to Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address significant unmet medical needs across neuropathi...

Latest Stock Quote

MIRA 2026-06-23 $0.954 O:$0.9503 H:$0.97 L:$0.9501 Vol:0.0M VWAP:$0.9509
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-16

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-312025-12-310001493152-26-014001EDGAR68K words
2025-03-282024-12-310001641172-25-001183EDGAR—
2024-04-012023-12-310001493152-24-012141EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001493152-25-022112EDGAR15K words
2025-08-142025-06-300001641172-25-024077EDGAR—
2025-05-142025-03-310001641172-25-010301EDGAR—
2024-11-122024-09-300001493152-24-044747EDGAR—
2024-08-132024-06-300001493152-24-031612EDGAR—
2024-05-132024-03-310001493152-24-018908EDGAR—
2023-11-132023-09-300001493152-23-040517EDGAR—
2023-09-152023-06-300001493152-23-032778EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-060001493152-26-036262EDGAR—
2026-07-310001493152-26-035665EDGAR—
2026-03-230001493152-26-012085EDGAR1K words
2026-03-030001493152-26-008707EDGAR—
2026-02-020001493152-26-004739EDGAR—
2025-12-220001493152-25-028619EDGAR—
2025-12-050001493152-25-026445EDGAR—
2025-10-230001493152-25-019065EDGAR—
2025-10-160001493152-25-018303EDGAR—
2025-10-150001493152-25-018141EDGAR—

87 total filings indexed. 66 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Company Identity

CIK0001904286
TickerMIRA
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedFL
Websitehttps://www.mirapharmaceuticals.com
Listed2023-08-03

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: ef5c73a8b01ddf9a1dfcad7996dbf96609bf4158edff8b30fb17d61f08bd8825
parent: 40c5c47f9f298f198b5f7d8fa1738ca561d3aa8d6f3256d95985c29862fe8951
content hash: 2877d879aa2d4b5236634b16558d9a9a07982c6f4a4271eacd77fc28681fef8b
signed: 2026-08-11T12:03:57.313Z
sources: 11 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up MIRA using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on MIRA, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/MIRA (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.